Prognosis Research Strategy (PROGRESS) 2: prognostic factor research

Richard D Riley; Jill A Hayden; Ewout W Steyerberg; Karel G M Moons; Keith Abrams; Panayiotis A Kyzas; Núria Malats; Andrew Briggs; Sara Schroter; Douglas G Altman; Harry Hemingway; PROGRESS Group

doi:10.1371/journal.pmed.1001380

Prognosis Research Strategy (PROGRESS) 2: prognostic factor research

Richard D Riley, Jill A Hayden, Ewout W Steyerberg, Karel G M Moons, Keith Abrams, Panayiotis A Kyzas, Núria Malats, Andrew Briggs, Sara Schroter, Douglas G Altman, Harry Hemingway, PROGRESS Group

Research output: Contribution to journal › Article › peer-review

308 Citations (Scopus)

Abstract

Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.

Original language	English
Pages (from-to)	e1001380
Journal	PLoS Medicine
Volume	10
Issue number	2
DOIs	https://doi.org/10.1371/journal.pmed.1001380
Publication status	Published - Feb 2013

Access to Document

10.1371/journal.pmed.1001380

Cite this

@article{c0431e9643c941ac96972f078875b721,

title = "Prognosis Research Strategy (PROGRESS) 2: prognostic factor research",

abstract = "Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.",

author = "Riley, {Richard D} and Hayden, {Jill A} and Steyerberg, {Ewout W} and Moons, {Karel G M} and Keith Abrams and Kyzas, {Panayiotis A} and N{\'u}ria Malats and Andrew Briggs and Sara Schroter and Altman, {Douglas G} and Harry Hemingway and {PROGRESS Group}",

year = "2013",

month = feb,

doi = "10.1371/journal.pmed.1001380",

language = "English",

volume = "10",

pages = "e1001380",

journal = "PLoS Medicine",

issn = "1549-1676",

publisher = "Public Library of Science (PLOS)",

number = "2",

}

TY - JOUR

T1 - Prognosis Research Strategy (PROGRESS) 2

T2 - prognostic factor research

AU - Riley, Richard D

AU - Hayden, Jill A

AU - Steyerberg, Ewout W

AU - Moons, Karel G M

AU - Abrams, Keith

AU - Kyzas, Panayiotis A

AU - Malats, Núria

AU - Briggs, Andrew

AU - Schroter, Sara

AU - Altman, Douglas G

AU - Hemingway, Harry

AU - PROGRESS Group

PY - 2013/2

Y1 - 2013/2

N2 - Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.

AB - Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.

U2 - 10.1371/journal.pmed.1001380

DO - 10.1371/journal.pmed.1001380

M3 - Article

C2 - 23393429

SN - 1549-1676

VL - 10

SP - e1001380

JO - PLoS Medicine

JF - PLoS Medicine

IS - 2

ER -

Prognosis Research Strategy (PROGRESS) 2: prognostic factor research

Abstract

Access to Document

Fingerprint

Cite this